Understanding Patient Characteristics and Coronary Microvasculature: Early Insights from the Coronary Microvascular Disease Registry

被引:5
|
作者
Case, Brian C. [1 ]
Merdler, Ilan [1 ]
Medranda, Giorgio A. [2 ]
Zhang, Cheng [1 ]
Ozturk, Sevket Tolga [1 ]
Sawant, Vaishnavi [1 ]
Margulies, Adrian D. [1 ]
Ben-Dor, Itsik [1 ]
Waksman, Ron [1 ]
Hashim, Hayder D. [1 ]
机构
[1] MedStar Washington Hosp Ctr, Sect Intervent Cardiol, Washington, DC 20010 USA
[2] NYU, Div Cardiol, Dept Med, Langone Hosp, Mineola, NY USA
来源
关键词
chest pain; coronary microvascular dysfunction; stable angina; ischemic nonobstructive coronary artery; MICROCIRCULATORY RESISTANCE; FLOW RESERVE; DYSFUNCTION; ANGINA;
D O I
10.1016/j.amjcard.2023.07.159
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary angiography has limitations in accurately assessing the coronary microcirculation. A new comprehensive invasive hemodynamic assessment method utilizing coronary flow reserve (CFR) and the index of microvascular resistance (IMR) offers improved diagnostic capabilities. This study aimed to present early real-world experience with invasive hemodynamic assessment of the coronary microvasculature in symptomatic patients with nonobstructive coronary artery disease (CAD) from the Coronary Microvascular Disease Registry, which is a prospective, multi-center registry that standardized the evaluation of patients with angina and nonobstructive CAD who underwent invasive hemodynamic assessment of the coronary microvasculature using the Coroventis CoroFlow Cardiovascular System. All patients underwent comprehensive invasive hemodynamic assessment. Analysis was performed on the first 154 patients enrolled in the Coronary Microvascular Disease Registry; their mean age was 62.4 years and 65.6% were female. A notable proportion of patients (31.8%) presented with a Canadian Cardiovascular Society Angina Score of 3 or 4. Coronary microvascular dysfunction was diagnosed in 39 of 154 patients (25.3%), with mean fractional flow reserve of 0.89 +/- 0.43, mean resting full cycle ratio of 0.93 +/- 0.08, mean CFR of 1.8 +/- 0.9, and mean IMR of 36.26 +/- 19.23. No in-hospital adverse events were reported in the patients. This study demonstrates the potential of invasive hemodynamic assessment using CFR and IMR to accurately evaluate the coronary microvasculature in patients with nonobstructive CAD. These findings have important implications for improving the diagnosis and management of coronary microvascular dysfunction, leading to more targeted and effective therapies for patients with microvascular angina. (C) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码:97 / 103
页数:7
相关论文
共 50 条
  • [41] STATIN THERAPY IN PATIENTS WITH CEREBROVASCULAR DISEASE VERSUS CORONARY ARTERY DISEASE: INSIGHTS FROM THE PALM REGISTRY
    Xian, Ying
    Navar, Ann
    Li, Shuang
    Li, Zhuokai
    Roger, Veronique
    Virani, Salim
    Wilson, Peter
    Goldberg, Anne
    Robinson, Jennifer
    Koren, Andrew
    Louie, Michael
    Peterson, Eric
    Wang, Tracy
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1747 - 1747
  • [42] Heterogeneity of coronary microvascular function as a marker of early coronary atherosclerosis
    Wieneke, H
    Dagres, N
    Kuntz, S
    Schmermund, A
    CIRCULATION, 1999, 100 (18) : 556 - 556
  • [43] Acute coronary syndromes in the elderly: insights from the GRACE registry
    Lankes, W
    Gulba, D
    Johnson, J
    Forth, J
    EUROPEAN HEART JOURNAL, 2002, 23 : 502 - 502
  • [44] Outcomes of coronary artery aneurysms: insights from the Coronary Artery Ectasia and Aneurysm Registry (CAESAR)
    Candreva, Alessandro
    Huwiler, Jessica
    Gallo, Diego
    Schweiger, Victor
    Gilhofer, Thomas
    Leone, Roberta
    Rizzini, Maurizio Lodi
    Chiastra, Claudio
    Stehli, Julia
    Michel, Jonathan
    Gotschy, Alexander
    Ruschitzka, Frank
    Morbiducci, Umberto
    Templin, Christian
    SWISS MEDICAL WEEKLY, 2025, 155
  • [45] Percutaneous coronary intervention in side branch coronary arteries: Insights from the Japanese nationwide registry
    Murasato, Yoshinobu
    Yamaji, Kyohei
    Kohsaka, Shun
    Wada, Hideki
    Ishii, Hideki
    Kinoshita, Yoshihisa
    Shite, Junya
    Hikichi, Yutaka
    Amano, Tetsuya
    Ikari, Yuji
    IJC HEART & VASCULATURE, 2021, 36
  • [46] Microvascular complications, coronary artery disease and the risk of cardiovascular disease in diabetes patients undergoing coronary angiography: a cohort study from the Western Denmark Heart Registry
    Olesen, K.
    Gyldenkerne, C.
    Thrane, P. G.
    Maeng, M.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2404 - 2404
  • [47] Coronary Sinus Reducer Improves Myocardial Perfusion in a Patient With Angina, Hypertrophic Cardiomyopathy, and Coronary Microvascular Disease
    Hoole, Stephen P.
    Tweed, Katharine
    Williams, Lynne
    Weir-McCall, Jonathan
    CJC OPEN, 2024, 6 (11) : 1299 - 1302
  • [48] FIBRINOLYTIC FUNCTION IN SOUTH ASIANS AND EUROPEANS WITH CORONARY HEART DISEASE: INSIGHTS FROM THE PRACTICE REGISTRY
    Gupta, M.
    Teoh, H.
    Yi, Q.
    Strauss, M.
    Tsigoulis, M.
    Verma, S.
    Eikelboom, J. W.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 57D - 57D
  • [49] Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease
    Akhiyat, Nadia
    Lasho, Terra
    Ganji, Morsaleh
    Toya, Takumi
    Shi, Chang-Xin
    Chen, Xianfeng
    Braggio, Esteban
    Ahmad, Ali
    Corban, Michel T.
    Stewart, Keith
    Fernandez, Jenna
    Xie, Zhuoer
    Finke, Christy
    Lerman, Lilach O.
    Patnaik, Mrinal M.
    Lerman, Amir
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43 (05) : 774 - 783
  • [50] Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome
    Labazi, Hicham
    Trask, Aaron J.
    PHARMACOLOGICAL RESEARCH, 2017, 123 : 114 - 121